bs-2526R [Primary Antibody]
CD160/By55 Polyclonal Antibody
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]

Host: Rabbit

Target Protein: CD160/By55

Immunogen Range: 81-159/181

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 11126

Swiss Prot: O95971

Source: KLH conjugated synthetic peptide derived from human CD160

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.

Storage Condition: Store at -20°C for 12 months..

Background: CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-1000)

Cross Reactive Species: Human

Predicted Cross Reactive Species: Mouse

For research use only. Not intended for diagnostic or therapeutic use.


L1 rat brain, L2 rat kidney lysates probed (bs-2526R) at 1:200 in 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in 37˚C. Predicted and observed band size: 27kDa.

Formalin-fixed and paraffin-embedded human cervical carcinoma labeled with Rabbit Anti-CD160/By55 Polyclonal Antibody ( bs-2526R), Unconjugated at 1:200 followed by conjugation to the secondary antibody and DAB staining

Formalin-fixed and paraffin embedded rat brain labeled with Anti-CD160/BY55 Polyclonal Antibody (bs-2526R), Unconjugated at 1:200 followed by conjugation to the secondary antibody